Mark Cuban Weighs In on Musk and Ramaswamy's DOGE Ambitions Amid Regulatory Concerns
TL;DR Summary
Mark Cuban has expressed interest in collaborating with Elon Musk and Vivek Ramaswamy's Department of Government Efficiency (DOGE) to reduce federal healthcare costs. Cuban's company, Cost Plus Drugs, aims to lower prescription drug prices by eliminating intermediaries. If integrated into government programs like Medicare and Medicaid, it could offer significant savings. Cuban has previously engaged with Musk on drug pricing issues and remains open to partnerships that align with his company's cost-saving goals.
- Will Mark Cuban Join Rivals Elon Musk, Vivek Ramaswamy's DOGE? 'Shark Tank' Host Says 'Both Know How To Reach Me' - iShares U.S. Health Care Providers ETF (ARCA:IHF) Benzinga
- The Ramaswamy and Elon Musk-led DOGE could work — if MTG doesn't ruin it MSNBC
- Will Musk’s ‘Algorithm’ reduce military inefficiency—or increase risk? Defense One
- Musk’s Slashing of the Federal Budget Faces Big Hurdles The New York Times
- Musk's DOGE wants to slash regulations. Workers and patients may suffer, experts say. ABC News
Reading Insights
Total Reads
0
Unique Readers
12
Time Saved
2 min
vs 3 min read
Condensed
84%
464 → 73 words
Want the full story? Read the original article
Read on Benzinga